SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

23 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 1981.40 millions grew by 20.90 % from Rs. 1638.91 millions.Net profit declined -18.90% to Rs. 124.56 millions from Rs. 153.59 millions.Operating Profit reported a sharp decline to 200.69 millions from 220.46 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1981.40 1638.91 20.90 6615.15 6470.04 2.24 6615.15 6470.04 2.24
Other Income 13.98 28.22 -50.46 94.55 120.98 -21.85 94.55 120.98 -21.85
PBIDT 200.69 220.46 -8.97 703.64 872.47 -19.35 703.64 872.47 -19.35
Interest 0.34 1.01 -66.34 6.19 3.54 74.86 6.19 3.54 74.86
PBDT 200.35 219.45 -8.70 697.45 868.93 -19.73 697.45 868.93 -19.73
Depreciation 27.56 22.27 23.75 87.39 85.84 1.81 87.39 85.84 1.81
PBT 172.79 197.18 -12.37 610.06 783.09 -22.10 610.06 783.09 -22.10
TAX 48.23 43.59 10.64 136.53 182.52 -25.20 136.53 182.52 -25.20
Deferred Tax -5.93 -2.24 164.73 -16.52 3.59 -560.17 -16.52 3.59 -560.17
PAT 124.56 153.59 -18.90 473.53 600.57 -21.15 473.53 600.57 -21.15
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 10.13 13.45 -24.70 10.64 13.48 -21.12 10.64 13.48 -21.12

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×